|
|
||||||||
MICROBIAL PATHOGENICITY |





Shiraoka Chuo Sogo Hospital, Shiraoka, Saitama 329-0217, *Department of Infectious Diseases and Tropical Medicine, Research Institute International Medical Center of Japan, Shinjuku, Tokyo 162-8655,
Central Research Laboratory, Akita University School of Medicine, Akita 010-8543,
Department of Microbiology and
Department of Intensive and Critical Care Medicine, Jichi Medical School, minamikawachi-machi, Tochigi 329-0498, Japan
Corresponding author: Dr T. Kirikae (e-mail: tkirikae{at}ri.imcj.go.jp).
Received 15 Jan. 2001; accepted 17 April 2001.
Abstract
As assessed by the lipopolysaccharide (LPS)-specific chromogenic Limulus amoebocyte lysate (LAL) assay, Helicobacter pylori LPS extracted by the phenol-water procedure showed full potency to coagulate LAL, as did LPS from Salmonella minnesota and Escherichia coli. However, pretreatment of H. pylori LPS with polymyxin B, which easily destroys the endotoxic activity of enterobacterial LPS/lipid A, had little effect on the LAL coagulation activity, although the same treatment of E. coli LPS markedly diminished its activity. The H. pylori LPS induced very weak production of nitric oxide (NO) or tumour necrosis factor (TNF) by murine macrophages and TNF by human peripheral whole blood in vitro in comparison with S. minnesota LPS. These findings indicate that H. pylori LPS has the unique endotoxic characteristic of retaining full LAL coagulation activity with polymyxin B resistance, despite losing its endotoxic potencies such as the ability to induce NO and TNF production.
This article has been cited by other articles:
![]() |
K. Chochi, T. Ichikura, M. Kinoshita, T. Majima, N. Shinomiya, H. Tsujimoto, T. Kawabata, H. Sugasawa, S. Ono, S. Seki, et al. Helicobacter pylori Augments Growth of Gastric Cancers via the Lipopolysaccharide-Toll-like Receptor 4 Pathway whereas Its Lipopolysaccharide Attenuates Antitumor Activities of Human Mononuclear Cells Clin. Cancer Res., May 15, 2008; 14(10): 2909 - 2917. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Zughaier, B. Lindner, J. Howe, P. Garidel, M. H.J. Koch, K. Brandenburg, and D. S. Stephens Physicochemical characterization and biological activity of lipooligosaccharides and lipid A from Neisseria meningitidis Innate Immunity, December 1, 2007; 13(6): 343 - 357. [Abstract] [PDF] |
||||
![]() |
K. Kranzer, L. Sollner, M. Aigner, N. Lehn, L. Deml, M. Rehli, and W. Schneider-Brachert Impact of Helicobacter pylori Virulence Factors and Compounds on Activation and Maturation of Human Dendritic Cells Infect. Immun., July 1, 2005; 73(7): 4180 - 4189. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Enarsson, M. Brisslert, S. Backert, and M. Quiding-Jarbrink Helicobacter pylori Induces Transendothelial Migration of Activated Memory T Cells Infect. Immun., February 1, 2005; 73(2): 761 - 769. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Zughaier, Y.-L. Tzeng, S. M. Zimmer, A. Datta, R. W. Carlson, and D. S. Stephens Neisseria meningitidis Lipooligosaccharide Structure-Dependent Activation of the Macrophage CD14/Toll-Like Receptor 4 Pathway Infect. Immun., January 1, 2004; 72(1): 371 - 380. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | J MED MICROBIOL | MICROBIOLOGY | J GEN VIROL | ALL SGM JOURNALS |